TY - CHAP AU - Leone, M. AU - Martin, C. ED - Kuhlen, R. ED - Moreno, R. ED - Ranierie, M. ED - Rhodes, A. PY - 2007 DA - 2007// TI - Antibiotics in the ICU BT - 25 years of progress and innovation in intensive care medicine PB - Medizinisch Wissenschaftliche Verlagsgesellschaft CY - Berlin ID - Leone2007 ER - TY - STD TI - Kelly CP, LaMont T: Antibiotic-associated diarrhea caused by Clostridium difficile (Beyond the basics).http://www.uptodate.comAccessed20/04/2012, UR - http://www.uptodate.comAccessed20/04/2012 ID - ref2 ER - TY - BOOK AU - Bristol-Myers Squibb, H. L. PY - 2012 DA - 2012// TI - Amikacin Injection 100mg/2ml Summary of Product Characteristics PB - Irish Pharmaceutical Healthcare Association - medicines information online CY - Dublin ID - Bristol-Myers Squibb2012 ER - TY - BOOK AU - Winters, M. PY - 2010 DA - 2010// TI - Basic Clinical Pharmacokinetics PB - Lippincott Williams and Wilkins CY - New York ID - Winters2010 ER - TY - JOUR AU - Moore, R. AU - Smith, C. AU - Lietman, P. PY - 1984 DA - 1984// TI - Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia JO - Am J Med VL - 77 UR - https://doi.org/10.1016/0002-9343(84)90358-9 DO - 10.1016/0002-9343(84)90358-9 ID - Moore1984 ER - TY - JOUR AU - Moore, R. AU - Lietman, P. AU - Smith, C. PY - 1987 DA - 1987// TI - Clinical Response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration JO - J Infect Dis VL - 155 UR - https://doi.org/10.1093/infdis/155.1.93 DO - 10.1093/infdis/155.1.93 ID - Moore1987 ER - TY - JOUR AU - Roberts, J. AU - Kruger, P. AU - Paterson, D. AU - Lipman, J. PY - 2008 DA - 2008// TI - Antibiotic resistance- What's dosing got to do with it? JO - Crit Care Med VL - 36 UR - https://doi.org/10.1097/CCM.0b013e318180fe62 DO - 10.1097/CCM.0b013e318180fe62 ID - Roberts2008 ER - TY - JOUR AU - Barletta, J. AU - Johnson, S. AU - Nix, D. AU - Nix, L. AU - Erstad, B. PY - 2000 DA - 2000// TI - Population pharmacokinetics in critically ill trauma patients on once-daily regimens JO - J Trauma VL - 49 UR - https://doi.org/10.1097/00005373-200011000-00013 DO - 10.1097/00005373-200011000-00013 ID - Barletta2000 ER - TY - JOUR AU - Zaske, D. AU - Strate, R. AU - Kohls, P. PY - 1991 DA - 1991// TI - Amikacin pharmacokinetics: wide interpatient variation in 98 patients JO - J Clin Pharmacol VL - 31 UR - https://doi.org/10.1002/j.1552-4604.1991.tb03700.x DO - 10.1002/j.1552-4604.1991.tb03700.x ID - Zaske1991 ER - TY - JOUR AU - Lugo, G. AU - Castaneda-Hernandez, G. PY - 1997 DA - 1997// TI - Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis JO - Crit Care Med VL - 255 UR - https://doi.org/10.1097/00003246-199705000-00016 DO - 10.1097/00003246-199705000-00016 ID - Lugo1997 ER - TY - JOUR AU - Udy, A. AU - Roberts, J. AU - Lipman, J. PY - 2011 DA - 2011// TI - Implications of augmented renal clearance in critically ill patients JO - Nat Rev Nephrol VL - 7 ID - Udy2011 ER - TY - JOUR AU - Robert, R. AU - Rochard, E. AU - Malin, F. AU - Bouquet, S. PY - 1991 DA - 1991// TI - Amikacin pharmacokinetics during continuous veno-venous hemofiltration JO - Crit Care Med VL - 19 UR - https://doi.org/10.1097/00003246-199104000-00029 DO - 10.1097/00003246-199104000-00029 ID - Robert1991 ER - TY - JOUR AU - Armendariz, E. AU - Chelluri, L. AU - Ptachcinski, R. PY - 1990 DA - 1990// TI - Pharmacokinetics of amikacin during continuous venovenous hemofiltration JO - Crit Care Med VL - 18 UR - https://doi.org/10.1097/00003246-199006000-00023 DO - 10.1097/00003246-199006000-00023 ID - Armendariz1990 ER - TY - JOUR AU - Akers, K. AU - Cota, J. AU - Frei, C. AU - Chung, K. AU - Mende, K. AU - Murray, C. PY - 2011 DA - 2011// TI - Once-daily amikacin dosing in burns patients treated with continuous venovenous hemofiltration JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.00374-11 DO - 10.1128/AAC.00374-11 ID - Akers2011 ER - TY - JOUR AU - Pea, F. AU - Pierluigi, V. AU - Pavan, F. AU - Furlanut, M. PY - 2007 DA - 2007// TI - Pharmacokinetic considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy JO - Clin Pharmacokinet VL - 46 UR - https://doi.org/10.2165/00003088-200746120-00003 DO - 10.2165/00003088-200746120-00003 ID - Pea2007 ER - TY - JOUR AU - Moon, S. -. Y. AU - Oh, K. -. H. AU - Oh, Y. AU - Curie, A. AU - Joo, K. AU - Kim, Y. AU - Han, J. AU - Kim, S. AU - Lee, J. AU - Kim, J. -. R. PY - 2006 DA - 2006// TI - Removal of amikacin in patients undergoing continuous veno-venous hemodiafiltration JO - The Korean J Nephrology VL - 25 ID - Moon2006 ER - TY - JOUR AU - Taccone, F. S. AU - de Backer, D. AU - Laterre, P. -. F. AU - Spapen, H. AU - Dugernier, T. AU - Delattre, I. AU - Wallemacq, P. AU - Vincent, J. -. L. AU - Jacobs, F. PY - 2011 DA - 2011// TI - Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy JO - Int J Antimicrob Agents VL - 37 UR - https://doi.org/10.1016/j.ijantimicag.2011.01.026 DO - 10.1016/j.ijantimicag.2011.01.026 ID - Taccone2011 ER - TY - JOUR AU - Kinowski, J. AU - Coussaye, J. D. AU - Bressole, F. AU - Fabre, D. AU - Saissi, G. AU - Bouvet, O. AU - Galtier, M. AU - Eledjam, J. PY - 1993 DA - 1993// TI - Muliple-dose pharmacokinetics of amikacin and ceftaizidime in critically ill patients with septic multiple-organ failure during intermittent haemofiltration JO - Antimicrob Agents Chemother VL - 37 UR - https://doi.org/10.1128/AAC.37.3.464 DO - 10.1128/AAC.37.3.464 ID - Kinowski1993 ER - TY - JOUR AU - Layeux, B. AU - Taccone, F. AU - Fagnoul, D. AU - Vincent, J. -. L. AU - Jacobs, F. PY - 2010 DA - 2010// TI - Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00441-10 DO - 10.1128/AAC.00441-10 ID - Layeux2010 ER - TY - JOUR AU - Jelliffe, R. AU - Jelliffe, S. PY - 1972 DA - 1972// TI - A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex and weight JO - Math Biosci VL - 14 UR - https://doi.org/10.1016/0025-5564(72)90003-X DO - 10.1016/0025-5564(72)90003-X ID - Jelliffe1972 ER - TY - JOUR AU - Bressolle, F. AU - Gouby, A. AU - Martinez, J. -. M. AU - Joubert, P. AU - Saissi, G. AU - Guillaud, R. AU - Goment, R. PY - 1996 DA - 1996// TI - Population pharmacokinetics of amikacin in critically ill patients JO - Antimicrob Agents Chemother VL - 40 ID - Bressolle1996 ER - TY - JOUR AU - Marik, P. AU - Lipman, J. AU - Kobilski, S. AU - Scribante, J. PY - 1991 DA - 1991// TI - A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients JO - J Antimicrob Chemother VL - 28 UR - https://doi.org/10.1093/jac/28.5.753 DO - 10.1093/jac/28.5.753 ID - Marik1991 ER - TY - BOOK AU - Gabrielsson, J. AU - Weiner, D. PY - 2000 DA - 2000// TI - Pharmacokinetic and pharmacodynamic data analysis:concepts and applications PB - Swedish Pharmaceutical Press CY - Stockholm ID - Gabrielsson2000 ER - TY - JOUR AU - Sawchuk, R. AU - Zaske, D. PY - 1976 DA - 1976// TI - Pharmacokinetics of dosage regimens which utilize multiple intravenous infusions: gentamicin in burn patients JO - J Pharmackinet Biopharm VL - 4 UR - https://doi.org/10.1007/BF01086153 DO - 10.1007/BF01086153 ID - Sawchuk1976 ER - TY - JOUR AU - Ronchera-Oms, C. AU - Tormo, C. AU - Ordovas, J. AU - Abad, J. AU - Jimenez, N. PY - 1995 DA - 1995// TI - Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition JO - J Clin Pharm Ther VL - 20 UR - https://doi.org/10.1111/j.1365-2710.1995.tb00659.x DO - 10.1111/j.1365-2710.1995.tb00659.x ID - Ronchera-Oms1995 ER - TY - JOUR AU - Heintz, B. AU - Matzke, G. AU - Dager, W. PY - 2009 DA - 2009// TI - Antimicrobial dosing concepts and reccomendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis JO - Pharmacotherapy VL - 29 UR - https://doi.org/10.1592/phco.29.5.562 DO - 10.1592/phco.29.5.562 ID - Heintz2009 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/2050-6511/13/14/prepub UR - http://www.biomedcentral.com/2050-6511/13/14/prepub ID - ref27 ER -